3-(1H-Indol-3-yl)-4-(2-(4-methylpiperazin-1-yl)quinazolin-4-yl)-1H-pyrrole-2,5-dione, 98.0%, 250mg

GlcNAc beta(1-3)[Neu5Ac alpha(2-6)]GalNAc-alpha-pNP>97.0%(HPLC)2mg

Methyl4-[(E)-hydroxyiminomethyl]benzoate, 98%, 10g

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(7-methyl-1H-indol-3-yl)propanoic acid, 98+%, 25g

TERT-BUTYL N-([(2R)-5,5-DIFLUOROPIPERIDIN-2-YL]METHYL)CARBAMATE, 95.0%, 100mg

Plats de cristallisation DURAN® avec bec verseur, 100 ml, 70 mm, 10 Pièce(s)

4-(4-Methoxyphenyl)-1H-pyrazole, 250mg

3-(piperidin-4-yl)-3H,4H-pyrido[2,3-d]pyrimidin-4-one dihydrochloride, 95.0%, 250mg

2,3,4,5,6-Pentafluorobiphenyl, 98%, 5g

4-[4-(3-NITROPHENYL)-1H-1,2,3-TRIAZOL-1-YL]BUTAN-1-AMINE, 95.0%, 250mg

3-Bromo-4-iodopyridine, 97.0%, 1g

2-Bromo-4-ethylbenzaldehyde, 98%, 1g

2-METHOXY-4-(2-NITROETHYL)PHENOL, 95.0%, 5g